摘要
目的 :探讨活脑灵对轻中型高血压性脑出血的临床疗效。方法 :将 75例经CT诊断出血量 <30mL的高血压性基底节或丘脑出血病人随机分为 2组 ,治疗组 45例用活脑灵 2 0 0mg + 10 %葡萄糖 2 5 0mL静脉滴注 ,1次 /日 ,共 2 1次。对照组 30例用 10 %葡萄糖 2 5 0mL静脉滴注 ,1次 /日 ,共 2 1次。在用药前、后 1、2、3周根据改良爱丁堡与斯堪的那维亚评分法 ,对患者的神经系统损失状态进行评分 ,2周后复查CT。结果 :治疗组有效率为6 8 9% ,对照组为 43 3 % ,两组有统计学差异 (P <0 0 1) ,治疗组CT吸收率稍高于对照组 ,无 1例再出血发生。结论 :活脑灵是治疗轻中型高血压性脑出血的一种安全。
OBJECTIVE:To evaluate therapeutic effect of fonzylane treating mild and moderate hypertensional cerebral hemorrhage. METHOD:75 patients with hypertension,diagnosed of hemorrhage in basal ganglion or thalamus by CT,were divided into two group.The therapeutic group (45 patients) received intravenous dripping of fonzylane 200 mg plus 10% glucose 250 ml daily for 21 days.The control group (30 patients) was only dripped with 10% glucose 250 ml daily for 21 days.State of patients' nerve system was checked by of Scandinavian and Edinbourg rating criteria before treatment and the first three weeks after treatment.Patients were examed by CT after two weeks.RESULTS:Effective rate in therapeutic group was 68.9%,but 43.3% in control group.which was statistically significantly different between the two groups(P<0 01).There was a faster focus absorption under CT image and no rebleeding in therapeutic group.CONCLUSION:Fonzylane is a safe and effective drug in treatment of mild and moderate hypertensional cerebral hemorrhage.
出处
《九江医学》
2000年第4期199-200,共2页
Jiujiang Medical Journal
